New Technique in Congenital/Pediatric Cataract Surgery

Sponsor
Omer Othman Abdullah (Other)
Overall Status
Completed
CT.gov ID
NCT05278936
Collaborator
(none)
52
1
1
9
5.8

Study Details

Study Description

Brief Summary

In pediatric/congenital cataract surgery; multiple surgical interventions are performed, which needs multiple general anesthesias. Here, we describe a new technique, to end the operation in one session.

Condition or Disease Intervention/Treatment Phase
  • Other: The cataract surgery and the anterior vitrectomy
N/A

Detailed Description

Generally, in congenital/pediatric cataract surgery, it might be possible to different multiple procedures with multiple general anesthesias. Here, the investigators found a new procedure to perform the cataract removal, intraocular implantation, and the anterior vitrectomy all in one session through a sclero-corneal tunnel. The corneoscleral tunnels are covered by the conjunctiva to abolish the need for both suturing and repeated general anesthesia to remove corneal sutures.

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Simplified Sclerocorneal Incision/Tunnel in Performing Congenital/Pediatric Cataract Surgery
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Aug 1, 2021
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: A simplified sclero-cornel tunnel/incision in performing the congenital/pediatric cataract surgery

Participitant

Other: The cataract surgery and the anterior vitrectomy
Surgical

Outcome Measures

Primary Outcome Measures

  1. Slit-lamp examination [The fourth weeks postoperatively]

    To check the intra-ocular lens positioning

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Congenital/pediatric cataract
Exclusion Criteria:
  • Aphakic and pseudophakic

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ibinsina Modern eye and retina center Erbil Iraq 44001

Sponsors and Collaborators

  • Omer Othman Abdullah

Investigators

  • Principal Investigator: Omer Abdullah, M.Sc., Ibinsina Modern Eye and Retina Center
  • Study Director: Huseyin Oksuz, MD, Dunya Goz Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Omer Othman Abdullah, Associate consultant ophthalmologist, Ibinsina Modern Eye and Retina Center
ClinicalTrials.gov Identifier:
NCT05278936
Other Study ID Numbers:
  • IMER 1
First Posted:
Mar 14, 2022
Last Update Posted:
May 2, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Omer Othman Abdullah, Associate consultant ophthalmologist, Ibinsina Modern Eye and Retina Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 2, 2022